NCT06714162

Brief Summary

dietary supplement for healthy ageing

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 3, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

December 21, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

December 3, 2024

Status Verified

November 1, 2024

Enrollment Period

2 months

First QC Date

November 4, 2024

Last Update Submit

December 2, 2024

Conditions

Ageing Signs

Outcome Measures

Primary Outcomes (1)

  • Cogntiion

    Memory Test - Mini Mental State Exam where a higher score indicates a better memory

    12 weeks

Study Arms (1)

Experimental

EXPERIMENTAL

dietary supplement

Dietary Supplement: Longevity pill

Interventions

Longevity pillDIETARY_SUPPLEMENT

vitamins and herbs

Experimental

Eligibility Criteria

Age35 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Longevity

Intervention Hierarchy (Ancestors)

AgingGrowth and DevelopmentPhysiological Phenomena

Central Study Contacts

John Ademola, PhD

CONTACT

9148862769Jademola.sfinstitute@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

December 3, 2024

Study Start

December 21, 2024

Primary Completion

February 27, 2025

Study Completion

April 1, 2025

Last Updated

December 3, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

de identified data excel spreadheets

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
11/21/2024 - 4/15/2025
Access Criteria
data excel sheets de identified through encrypted email